Fibrin-mediated Protection Against Infection-stimulated Immunopathology
Open Access
- 10 March 2003
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 197 (6) , 801-806
- https://doi.org/10.1084/jem.20021493
Abstract
Fibrin, a product of the blood coagulation cascade, accompanies many type 1 immune responses, including delayed-type hypersensitivity, autoimmunity, and graft rejection. In those settings, fibrin is thought to exacerbate inflammation and disease. Here, we evaluate roles for coagulation during infection with Toxoplasma gondii, a pathogen whose control requires robust type 1 immunity. We establish that fibrin prevents infection-stimulated blood loss, thereby performing a protective function that is essential for survival. Remarkably, fibrin does not simply protect against vascular damage caused directly by the infectious agent, but rather, protects against hemorrhage evoked by interferon-γ, a critical mediator of type 1 immunity. This finding, to our knowledge, is the first to document a beneficial role for coagulation during type 1 immunity, and suggests that fibrin deposition protects host tissue from collateral damage caused by the immune system as it combats infection.Keywords
This publication has 35 references indexed in Scilit:
- Variable protection of β3-integrin–deficient mice from thrombosis initiated by different mechanismsBlood, 2001
- QUANTIFICATION OF MURINE CYTOKINE mRNAs USING REAL TIME QUANTITATIVE REVERSE TRANSCRIPTASE PCRCytokine, 1999
- Exacerbation of antigen-induced arthritis in urokinase-deficient mice.Journal of Clinical Investigation, 1998
- A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.Journal of Clinical Investigation, 1998
- Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic GlomerulonephritisThe Journal of Experimental Medicine, 1997
- PARTICIPATION OF CELL-MEDIATED IMMUNITY IN DEPOSITION OF FIBRIN IN GLOMERULONEPHRITISThe Lancet, 1988
- Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondiiScience, 1988
- Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response.The Journal of Experimental Medicine, 1979
- Delayed-Type Hypersensitivity Skin Reactions in Congenital Afibrinogenemia Lack Fibrin Deposition and IndurationJournal of Clinical Investigation, 1979
- Delayed Hypersensitivity in Man: Effects of Systemic AnticoagulationScience, 1978